Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 9381-9382 [2017-02368]
Download as PDF
<![CDATA[
sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 23 / Monday, February 6, 2017 / Notices
collection techniques or other forms of
information technology; and ways to
further reduce the information
collection burden on small business
concerns with fewer than 25 employees.
The FCC may not conduct or sponsor
a collection of information unless it
displays a currently valid OMB control
number. No person shall be subject to
any penalty for failing to comply with
a collection of information subject to the
PRA that does not display a valid OMB
control number.
DATES: Written PRA comments should
be submitted on or before April 7, 2017.
If you anticipate that you will be
submitting comments, but find it
difficult to do so within the period of
time allowed by this notice, you should
advise the contact listed below as soon
as possible.
ADDRESSES: Direct all PRA comments to
Cathy Williams, FCC, via email PRA@
fcc.gov and to Cathy.Williams@fcc.gov.
FOR FURTHER INFORMATION CONTACT: For
additional information about the
information collection, contact Cathy
Williams at (202) 418–2918.
SUPPLEMENTARY INFORMATION: As part of
its continuing effort to reduce
paperwork burdens, and as required by
the Paperwork Reduction Act (PRA) of
1995 (44 U.S.C. 3501–3520), the Federal
Communications Commission (FCC or
Commission) invites the general public
and other Federal agencies to take this
opportunity to comment on the
following information collections.
Comments are requested concerning:
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
Commission, including whether the
information shall have practical utility;
the accuracy of the Commission’s
burden estimate; ways to enhance the
quality, utility, and clarity of the
information collected; ways to minimize
the burden of the collection of
information on the respondents,
including the use of automated
collection techniques or other forms of
information technology; and ways to
further reduce the information
collection burden on small business
concerns with fewer than 25 employees.
OMB Control Number: 3060–1022.
Title: Sections 101.1403, 101.103(f),
101.1413, 101.1440 and 101.1417,
MVDDS and DBS Reporting and Third
Party Disclosure Requirements.
Form Number: N/A.
Type of Review: Extension of a
currently approved collection.
Respondents: Business or other forprofit entities.
Number of Respondents: 12
respondents; 101 responses.
VerDate Sep<11>2014
16:03 Feb 03, 2017
Jkt 241001
Estimated Time per Response: 0.5
hour–40 hours.
Frequency of Response: Annual and
on occasion reporting requirements; 5
and 10 years reporting requirements;
third party disclosure requirement.
Obligation to Respond: Required to
obtain or retain benefits. 47 U.S.C.
154(i), 157(a), 301, 303(c), 303(f), 303(g),
303(r), 308, and 309(j).
Total Annual Burden: 543 hours.
Total Annual Cost: $8,100.
Privacy Impact Assessment: No
impact(s).
Nature and Extent of Confidentiality:
There is no need for confidentiality with
this collection of information.
Needs and Uses: The Commission
uses the information to ensure that
Multichannel Video Distribution and
Data Service (MVDDS) licensees meet
the broadcast carriage requirements; to
ensure that MVDDS antennas meet
minimum spacing requirement; to
determine whether a licensee is
providing substantial service; to ensure
that MVDDS licensees protect DBS
customers of record from interference as
required by the Commission’s rules; and
to keep track of the MVDDS service. The
information compiled in the annual
report will assist the Commission in
analyzing trends and competition in the
marketplace.
Federal Communications Commission.
Marlene H. Dortch,
Secretary, Office of the Secretary.
[FR Doc. 2017–02399 Filed 2–3–17; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL ELECTION COMMISSION
Sunshine Act Meetings
Federal Election Commission.
Thursday, February 9,
2017 at 10:00 a.m.
PLACE: 999 E Street NW., Washington,
DC (Ninth Floor).
STATUS: This meeting will be open to
the public.
ITEMS TO BE DISCUSSED:
Proposed Final Audit Report on the
Conservative Campaign Committee
(A13–15)
Audit Division Recommendation
Memorandum on the Kansas
Democratic Party (KDP) (A13–08)
Audit Division Recommendation
Memorandum on Kind for Congress
Committee (KFCC) (A15–02)
Management and Administrative
Matters
Individuals who plan to attend and
require special assistance, such as sign
language interpretation or other
AGENCY:
DATE AND TIME:
PO 00000
Frm 00012
Fmt 4703
Sfmt 4703
9381
reasonable accommodations, should
contact Dayna C. Brown, Acting
Secretary and Clerk, at (202) 694–1040,
at least 72 hours prior to the meeting
date.
PERSON TO CONTACT FOR INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
Dayna C. Brown,
Acting Secretary and Clerk of the
Commission.
[FR Doc. 2017–02513 Filed 2–2–17; 4:15 pm]
BILLING CODE 6715–01–P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than March 3, 2017.
A. Federal Reserve Bank of
Minneapolis (Jacquelyn K. Brunmeier,
Assistant Vice President) 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291:
1. Signature Bancshares, Inc.
Employee Stock Ownership Plan &
Trust, Minnesota; to become a bank
holding company by acquiring up to 35
percent of the voting shares of Signature
Bancshares, Inc., Minnetonka,
E:\FR\FM\06FEN1.SGM
06FEN1
9382
Federal Register / Vol. 82, No. 23 / Monday, February 6, 2017 / Notices
Minnesota, and thereby indirectly
acquire Signature Bank, Minnetonka,
Minnesota.
B. Federal Reserve Bank of San
Francisco (Gerald C. Tsai, Director,
Applications and Enforcement) 101
Market Street, San Francisco, California
94105–1579:
1. Carpenter Bank Partners, Inc.,
CCFW, Inc., Carpenter Fund Manager
GP, LLC, Carpenter Fund Management
Company, LLC, Carpenter Community
BancFund, L.P., Carpenter Community
BancFund-A, L.P., and Carpenter
Community BancFund, L.P., all Irvine,
California; to acquire Pacific Premier
Bancorp and thereby indirectly acquire
Pacific Premier Bank, Irvine, California.
Board of Governors of the Federal Reserve
System, January 31, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–02368 Filed 2–3–17; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–N–0001]
Advisory Committee Nominations;
Modification To Process for Collecting
and Posting Curricula Vitae
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA, Agency, or we) is
modifying the process by which we
collect and post curricula vitae (CVs) of
advisory committee members so that the
CVs will be posted to our Web site
without removing or redacting any
information. Posting CVs without
removing or redacting any information
will increase the transparency of FDA’s
selection of officials who serve on
advisory committees, and will ensure
greater public access to the
qualifications of advisory committee
members on an ongoing basis. Because
advisory committee members are best
situated to determine whether there is
confidential information in their CVs,
this modified collection and posting
process will conserve FDA resources
because FDA personnel will no longer
be responsible for reviewing and
redacting the CVs.
DATES: All nominees for positions on an
FDA advisory committee will be
required to submit a consent form on or
after the date of the Office of
Management and Budget (OMB)
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:03 Feb 03, 2017
Jkt 241001
approval for this information collection,
authorizing FDA to publicly post an unredacted copy of their CV on FDA’s Web
site. Elsewhere in this issue of the
Federal Register, FDA is publishing the
notice for the proposed information
collection. Additionally, effective March
8, 2017, all existing advisory committee
members who submit an updated
version of their CV to FDA will be
required to submit a consent form along
with their CV.
FOR FURTHER INFORMATION CONTACT:
Questions should be sent electronically
to ACOMSSubmissions@fda.hhs.gov, or
by mail to Advisory Committee
Oversight and Management Staff, 10903
New Hampshire Ave., Bldg. 32, Rm.
5129, Silver Spring, MD 20993–0002.
SUPPLEMENTARY INFORMATION:
I. Background
FDA generally has posted the CVs of
FDA advisory committee members
publicly on https://www.fda.gov/
AdvisoryCommittees/ after reviewing
the CVs and redacting information that
appeared to be confidential. Currently,
FDA requires the submission of a CV for
each nominee as part of the nomination
process for advisory committee
members. FDA also requests that
existing advisory committee members
submit updated versions of their CVs,
typically on a yearly basis.
In furtherance of FDA’s goal of
ensuring transparency regarding the
qualifications of individuals selected to
serve on FDA advisory committees, and
in recognition that individual advisory
committee members are best situated to
evaluate the confidentiality of
information contained in their CVs,
including any considerations raised by
their relationships and agreements with
third parties, FDA will be requiring that
all CVs submitted as part of the
nomination process for positions on
FDA advisory committees be
accompanied by a written consent form
stating that, if the nominee is accepted
as a member of an FDA advisory
committee, the individual consents to
the publication of the individual’s CV to
FDA’s Web site, without FDA removing
or redacting any information. The
consent form requires that the nominee
affirm that the CV does not include any
confidential information, including
information pertaining to third parties
that the nominee is not permitted to
disclose. A nominee will be required to
submit a signed consent form in order
for the nomination to be considered
complete. The consent form will need to
be submitted along with the four other
types of documents currently requested
as part of the nomination process: (1) A
PO 00000
Frm 00013
Fmt 4703
Sfmt 4703
CV for each nominee; (2) a written
confirmation that the nominee is aware
of the nomination (unless selfnominated); (3) a letter(s) of
recommendation; and (4) for Consumer
Representative applications, a cover
letter that lists consumer or community
organizations for which the candidate
can demonstrate active participation. In
addition to the consent form submitted
as part of the application process, FDA
will also be requiring that a nearly
identical consent form be submitted by
all existing advisory committee
members each time they submit an
updated version of their CV to FDA. The
language of the consent for existing
advisory committee members will differ
only in that it will not include the
language ‘‘if [the nominee is] selected to
serve on an [FDA] advisory committee’’.
Every day, FDA makes important
health and safety decisions about foods,
drugs, medical devices, cosmetics, and
other widely used consumer products.
Transparency in FDA’s activities and
decision making allows the public to
better understand the Agency’s
decisions, increasing credibility and
promoting accountability. Transparency
helps the Agency to more effectively
protect and promote the public health.
Ensuring greater public awareness of the
qualifications of individuals responsible
for assisting the Agency in making
important policy decisions is an
important factor in ensuring such
transparency. Posting the CVs of
advisory committee members helps
increase public awareness.
Additionally, requiring advisory
committee nominees and advisory
committee members to attest that their
CVs do not include any confidential
information, including information
pertaining to third parties that they are
not permitted to disclose, will help
conserve limited FDA resources by
ensuring that the individual most
familiar with the information contained
in the CV, as well as any contractual or
confidentiality agreements that might
affect their ability to disclose that
information, assumes the responsibility
for determining whether the information
may be released publicly. Because
advisory committee nominees and
members are most familiar with the
information contained in their CVs,
FDA will not be advising potential or
current members about whether specific
information in their CVs is confidential
or otherwise should be removed.
II. Advisory Committee Member CVs
and Confidential Information
The consent form will be required to
be submitted each time an advisory
committee nominee’s or existing
E:\FR\FM\06FEN1.SGM
06FEN1
]]>Agencies
[Federal Register Volume 82, Number 23 (Monday, February 6, 2017)]
[Notices]
[Pages 9381-9382]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02368]
=======================================================================
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and Mergers of Bank Holding
Companies
The companies listed in this notice have applied to the Board for
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C.
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other
applicable statutes and regulations to become a bank holding company
and/or to acquire the assets or the ownership of, control of, or the
power to vote shares of a bank or bank holding company and all of the
banks and nonbanking companies owned by the bank holding company,
including the companies listed below.
The applications listed below, as well as other related filings
required by the Board, are available for immediate inspection at the
Federal Reserve Bank indicated. The applications will also be available
for inspection at the offices of the Board of Governors. Interested
persons may express their views in writing on the standards enumerated
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the
acquisition of a nonbanking company, the review also includes whether
the acquisition of the nonbanking company complies with the standards
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted,
nonbanking activities will be conducted throughout the United States.
Unless otherwise noted, comments regarding each of these
applications must be received at the Reserve Bank indicated or the
offices of the Board of Governors not later than March 3, 2017.
A. Federal Reserve Bank of Minneapolis (Jacquelyn K. Brunmeier,
Assistant Vice President) 90 Hennepin Avenue, Minneapolis, Minnesota
55480-0291:
1. Signature Bancshares, Inc. Employee Stock Ownership Plan &
Trust, Minnesota; to become a bank holding company by acquiring up to
35 percent of the voting shares of Signature Bancshares, Inc.,
Minnetonka,
[[Page 9382]]
Minnesota, and thereby indirectly acquire Signature Bank, Minnetonka,
Minnesota.
B. Federal Reserve Bank of San Francisco (Gerald C. Tsai, Director,
Applications and Enforcement) 101 Market Street, San Francisco,
California 94105-1579:
1. Carpenter Bank Partners, Inc., CCFW, Inc., Carpenter Fund
Manager GP, LLC, Carpenter Fund Management Company, LLC, Carpenter
Community BancFund, L.P., Carpenter Community BancFund-A, L.P., and
Carpenter Community BancFund, L.P., all Irvine, California; to acquire
Pacific Premier Bancorp and thereby indirectly acquire Pacific Premier
Bank, Irvine, California.
Board of Governors of the Federal Reserve System, January 31,
2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017-02368 Filed 2-3-17; 8:45 am]
BILLING CODE 6210-01-P
